Improving Healthcare Outcomes With Early Detection of Liver Related Complications in Liver Cirrhosis Patients by Implementing a Telemedicine Care Pathway (myLIVERcoach)

Summary

The goal of this multicenter feasibility study is to investigate the feasibility of our telemedicine platform (myLIVERcoach) in liver cirrhosis patients, according to liver cirrhosis patients, caregivers and healthcare professionals. The main question\[s\] it aims to answer are:

1. What is the feasibility of a telemonitoring pathway according to patients, caregivers and healthcare professionals in liver cirrhosis care?

Secondary objectives:
2. What is the level of acceptability, usability, learnability and desirability of a telemonitoring pathway in liver cirrhosis care from the patients, caregivers and healthcare professionals' perspective?
3. What is the level of compliance of patients, caregivers and healthcare professionals using a telemonitoring pathway in liver cirrhosis care?
4. What is the occurrence of liver related complications in liver cirrhosis patients using a telemonitoring pathway?
5. What is the occurrence of clinical admissions and emergency concultations in liver cirrhosis patients using a telemonitoring pathway?
6. What is the mortality rate in liver cirrhosis patients using a telemonitoring pathway?

8\. What is the effect of a telemonitoring pathway on patients perceived health, quality of life and work participation of liver cirrhosis patients?

Participants will be asked to use myLIVERcoach on top of standard care. According to disease stadium participants will receive different online questionnaires and measurements, focusing on early detection of complications and psychosocial and lifestyle factors. Participants are able to contact their healthcare professional and go through information about their disease as well.

After six months, participants will be asked to fill out a questionnaire regarding their experiences with myLIVERcoach in order to optimize the system. In addition the investigators will perform interviews with ten patients or caregivers and with healthcare professionals at the end of follow-up.

Conditions

• Liver Cirrhosis

Interventions

DEVICE

telemedicine pathway

Patients are able to use an online application on top of standard care. Monitoring complications, subjective wellbeing and lifestyle factors. Patients are able to go through information about liver cirrhosis and additional aspects, like dietary advices, at any moment in time. Furthermore, they are able to contact their healthcare professional through the chat function.

Sponsors & Collaborators

• Dutch Digestive Diseases Foundation

  collaborator OTHER

• Gelre Hospitals

  collaborator OTHER

• Maastricht University Medical Center

  collaborator OTHER

• Maastricht University

  lead OTHER

Study Design

Allocation

NA

Purpose

OTHER

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-05-01

Primary Completion

2025-05-01

Completion

2025-05-01

Countries

• Netherlands

Study Locations